This is an excerpt from Medically Necessary, a health care supply chain newsletter. Subscribe here.
The idea: A California company producing active pharmaceutical ingredients with engineered yeast raised $73 million to bring its first product to market.
The company, Antheia, will focus on making complex chemicals normally extracted from plants.
The funding was led by Viking Global Investors and included Sherpalo Ventures and Hillspire. The new funding comes amid a push from policymakers to...
https://www.freightwaves.com/news/startup-using-yeast-to-make-drug-components-raises-73m